An act relating to medical debt relief and excluding medical debt from credit reports
H.112 is a medical debt relief and consumer protection bill. It would appropriate $1 million in fiscal year 2026 for the State Treasurer to contract with a nonprofit entity to buy certain qualifying medical debts from health care providers at fair market value and then abolish those debts. The relief would be targeted to Vermont residents with household incomes at or below 400 percent of the federal poverty level, or residents whose medical debt equals at least 5 percent of household income, so long as the debt remains outstanding after routine collection efforts.
The bill also seeks to remove medical debt from consumer credit reporting. It would prohibit credit reporting agencies from reporting or maintaining medical debt information, bar health care providers and medical debt collectors from furnishing medical debt to credit bureaus, and require related consumer disclosures to reflect these restrictions. In addition, it would allow large health care facilities to transfer medical debt only to a 501(c)(3) organization for the limited purpose of canceling the debt, and it would exempt such eligibility determinations from certain credit-reporting disclosure rules.
The bill’s impact on state law would be significant in both the health care and consumer credit areas. It amends Vermont’s consumer protection statutes and health care debt provisions to create a new framework for medical debt abolition, restricts the sale and reporting of medical debt, and changes how credit reporting agencies and health care providers may handle medical debt information. It also adjusts a prior appropriation related to state bond redemption, reducing that amount from $20 million to $19 million to help fund the new program.
Because there are no committee transcripts or recorded votes provided, the overall sentiment cannot be measured from debate history. Based on the bill text, the measure appears strongly consumer- and patient-focused, aiming to reduce the financial and credit harms associated with medical debt. The absence of recorded opposition or amendments in the provided materials suggests no documented controversy in the available record.
The main points of potential contention, based on the structure of the bill, would likely involve the use of state funds, the role of government in purchasing private debt, and the impact on health care providers and credit reporting practices. Stakeholders who might support the bill include consumer advocates, debt relief organizations, and patients with medical debt, while potential concerns could come from providers, collectors, and credit reporting interests regarding costs, administrative burden, and limits on debt recovery.
The bill would amend Vermont law to create a state-supported medical debt abolition program, restrict the sale and transfer of medical debt, and prohibit credit reporting of medical debt by agencies, providers, and collectors. It would also modify consumer disclosure rules and related exemptions in Title 9 and Title 18, while reducing a prior bond-redemption appropriation by $1 million to fund the new initiative.
No committee testimony or vote history is provided, so there is no recorded legislative sentiment to summarize. On its face, the bill reflects a favorable policy approach toward debt relief and consumer protection, with the text designed to eliminate medical debt burdens and prevent credit damage for affected Vermonters.
The likely areas of contention are fiscal and operational rather than ideological: whether the state should spend $1 million to purchase and cancel private medical debt, whether limiting medical debt reporting could affect provider collections, and whether the bill’s restrictions on debt sales and credit reporting are too broad. Support would likely come from patient advocates and consumer protection groups, while health care providers, debt buyers, and credit reporting stakeholders may raise concerns about revenue, compliance, and credit market impacts.